Hyperbaric oxygen therapy for chronic radiotherapy‐related adverse effects: A clinically focused review
CA: A Cancer Journal for Clinicians · 2026
DOI: 10.3322/caac.70058 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift CA: A Cancer Journal for Clinicians, 2026. Verfasst von Cas Stefaan Dejonckheere und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, University Hospital Bonn, Bonn, Germany. Hauptthemen laut MEDLINE: Hyperbaric Oxygenation, Radiation Injuries, Neoplasms, Radiotherapy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Radiotherapy is a cornerstone of modern oncologic care, yet its sequelae can significantly impair survivors' quality of life. Chronic radiation‐induced conditions—including skin fibrosis, bone necrosis, radiation cystitis, and proctitis—pose substantial challenges for both patients and caregivers, particularly in the context of improving long‐term cancer survival. Hyperbaric oxygen therapy, characterized by the promotion of angiogenesis, fibroblast activation, and tissue remodeling in hypoxic environments, has emerged as a potential adjunctive treatment for mitigating these late effects. Herein, the authors critically evaluate randomized trials, cohort studies, and real‐world data while highlighting gaps in knowledge, including patient selection, optimal treatment protocols, and long‐term outcomes. In addition, they discuss practical considerations and health system implications of the integration of hyperbaric oxygen therapy into survivorship care. The objective of this review is to provide clinicians with an evidence‐informed framework to guide decision making in the multidisciplinary management of radiation‐related late effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, University Hospital Bonn, Bonn, Germany.
- Department of Radiation Oncology, University Hospital München, Munich, Germany.
- Department of Radiation Oncology, Klinikum Landshut, Landshut, Germany.
- Department of Radiation Oncology, Cologne Municipal Hospitals, University Hospital of the University of Witten-Herdecke, Cologne, Germany.
- Federal Association of Laryngeal and Head and Neck Tumors e.V., Bonn, Germany.
- Department of Gynecology, Division of Gynecological Oncology, University Hospital Bonn, Bonn, Germany.
ORCID-Profile: Cas Stefaan Dejonckheere, Lukas Käsmann, Leonard Christopher Schmeel, Gustavo Renato Sarria, Eleni Gkika
Zitieren
APA
Dejonckheere, C. S., Käsmann, L., Schmeel, L. C., Walter, S., Anzböck, T., Dreyer, S., Sarria, G. R., Gkika, E., & Layer, J. P. (2026). Hyperbaric oxygen therapy for chronic radiotherapy‐related adverse effects: A clinically focused review. CA: A Cancer Journal for Clinicians. https://doi.org/10.3322/caac.70058
Vancouver
Dejonckheere CS, Käsmann L, Schmeel LC, Walter S, Anzböck T, Dreyer S, et al. Hyperbaric oxygen therapy for chronic radiotherapy‐related adverse effects: A clinically focused review. CA: A Cancer Journal for Clinicians. 2026. doi:10.3322/caac.70058
BibTeX
@article{Dejonckheere2026,
author = {Dejonckheere, Cas Stefaan and Käsmann, Lukas and Schmeel, Leonard Christopher and Walter, Stefanie and Anzböck, Teresa and Dreyer, Sven and Sarria, Gustavo Renato and Gkika, Eleni and Layer, Julian Philipp},
title = {Hyperbaric oxygen therapy for chronic radiotherapy‐related adverse effects: A clinically focused review},
journal = {CA: A Cancer Journal for Clinicians},
year = {2026},
doi = {10.3322/caac.70058}
}
EUVIMED